☰

Hongkun Wang, Ph.D. - Publications

Affiliations: 
2005 University of Rochester, Rochester, NY 
Area:
Biostatistics Biology, Health Care Management
Tree Info Similar researchers PubMed Report error

31 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Pishvaian MJ, Wang H, He AR, Hwang JJ, Smaglo BG, Kim SS, Weinberg BA, Weiner LM, Marshall JL, Brody JR. A Phase I/II Study of Veliparib (ABT-888) in combination with 5-Fluorouracil and Oxaliplatin in Patients with Metastatic Pancreatic Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32669374 DOI: 10.1158/1078-0432.Ccr-20-1301  0.304
2020 Heeke AL, Pishvaian M, Wang H, Cohen A, Schlom J, Donahue R, Jochems C, Gatti-Mays M, Pohlmann P, Tan A, Isaacs C, Lynce F. Abstract OT2-03-04: A trial of induction Talazoparib followed by a combination of Talazoparib and Avelumab in advanced breast cancer: The TALAVE study Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-Ot2-03-04  0.306
2019 Khoury K, Isaacs C, Gatti-Mays M, Donahue R, Schlom J, Wang H, Gallagher C, Graham D, Warren R, Dilawari A, Swain S, Pohlmann P, Lynce F. Abstract OT3-04-01: Nivolumab or capecitabine or combination therapy as adjuvant therapy for triple negative breast cancer (TNBC) with residual disease following neoadjuvant chemotherapy: The OXEL study Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-Ot3-04-01  0.309
2017 He AR, Morse M, Iyer RV, Sohal D, Wang H, Dorsch-Vogel K, Pishvaian MJ, Salem ME, Smaglo BG, Marshall J. A phase II multicenter study evaluating combination immunotherapy with pembrolizumab and peginterferon alfa-2b for advanced cholangiocarcinoma. Journal of Clinical Oncology. 35. DOI: 10.1200/Jco.2017.35.4_Suppl.Tps507  0.302
2016 Hong W, Li L, Xue R, Xu X, Wang H, Zhou J, Zhao H, Song Y, Liu Y, Gao J. One-pot hydrothermal synthesis of Zinc ferrite/reduced graphene oxide as an efficient electrocatalyst for oxygen reduction reaction. Journal of Colloid and Interface Science. 485: 175-182. PMID 27664525 DOI: 10.1016/J.Jcis.2016.04.035  0.304
2016 Ren W, Zuo R, Wang YN, Wang HJ, Yang J, Xin SK, Han LY, Zhao HY, Han SY, Gao B, Hu H, Hu YJ, Bian BL, Si N. Pharmacokinetic-Pharmacodynamic Analysis on Inflammation Rat Model after Oral Administration of Huang Lian Jie Du Decoction. Plos One. 11: e0156256. PMID 27280291 DOI: 10.1371/journal.pone.0156256  0.311
2016 Zhou Z, Chen S, Zhao H, Wang C, Gao K, Guo Y, Shen Z, Wang Y, Wang H, Mei X. Probucol inhibits neural cell apoptosis via inhibition of mTOR signaling pathway after spinal cord injury. Neuroscience. PMID 27223630 DOI: 10.1016/j.neuroscience.2016.05.019  0.302
2016 Zhao HW, Zhang ZF, Chai X, Li GQ, Cui HR, Wang HB, Meng YK, Liu HM, Wang JB, Li RS, Bai ZF, Xiao XH. Oxymatrine attenuates CCl4-induced hepatic fibrosis via modulation of TLR4-dependent inflammatory and TGF-β1 signaling pathways. International Immunopharmacology. 36: 249-255. PMID 27179304 DOI: 10.1016/j.intimp.2016.04.040  0.31
2016 Wang HJ, Li XF, Liu L, Xu YP, Ye Q, Deng YQ, Huang XY, Zhao H, Qin ED, Shi PY, Gao GF, Qin CF. The Emerging Duck Flavivirus is not Pathogenic for Primates and is Highly Sensitive to Mammal Interferon Signaling. Journal of Virology. PMID 27147750 DOI: 10.1128/JVI.00197-16  0.312
2016 Xie J, Deng J, Fan X, Xie J, Zhao H, Qian D, Wang H. Computational design and fabrication of core-shell magnetic molecularly imprinted polymer for dispersive micro-solid-phase extraction coupled with high-performance liquid chromatography for the determination of rhodamine 6G. Journal of Separation Science. PMID 27120290 DOI: 10.1002/jssc.201600261  0.301
2016 Zhang Y, Wang YZ, Huang LP, Bai B, Zhou S, Yin MM, Zhao H, Zhou XN, Wang HT. Aquatic Therapy Improves Outcomes for Subacute Stroke Patients by Enhancing Muscular Strength of Paretic Lower Limbs Without Increasing Spasticity: A Randomized Controlled Trial. American Journal of Physical Medicine & Rehabilitation / Association of Academic Physiatrists. PMID 27088480 DOI: 10.1097/PHM.0000000000000512  0.316
2016 Liu C, Wang H, Shang Y, Liu W, Song Z, Zhao H, Wang L, Jia P, Gao F, Xu Z, Yang L, Gao F, Li W. Autophagy is required for ectoplasmic specialization assembly in Sertoli cells. Autophagy. 0. PMID 26986811 DOI: 10.1080/15548627.2016.1159377  0.306
2016 Zhao H, Wang H, Bauzon F, Lu Z, Fu H, Cui J, Zhu L. Deletions Of Retinoblastoma 1 (Rb1) And Its Repressing Target S-phase kinase-associated protein 2 (Skp2) Are Synthetic Lethal In Mouse Embryogenesis. The Journal of Biological Chemistry. PMID 26966181 DOI: 10.1074/jbc.M116.718049  0.316
2016 Qu F, Qiao Q, Wang N, Ji G, Zhao H, He L, Wang H, Bao G. Genetic polymorphisms in circadian negative feedback regulation genes predict overall survival and response to chemotherapy in gastric cancer patients. Scientific Reports. 6: 22424. PMID 26927666 DOI: 10.1038/srep22424  0.317
2016 Li G, Zhao H, Wang H, Guo X, Guo X, Sun Q, Xu B. Characterization of a Decapentapletic Gene (AccDpp) from Apis cerana cerana and Its Possible Involvement in Development and Response to Oxidative Stress. Plos One. 11: e0149117. PMID 26881804 DOI: 10.1371/journal.pone.0149117  0.313
2016 Han L, Wang H, Si N, Ren W, Gao B, Li Y, Yang J, Xu M, Zhao H, Bian B. Metabolites profiling of 10 bufadienolides in human liver microsomes and their cytotoxicity variation in HepG2 cell. Analytical and Bioanalytical Chemistry. PMID 26869342 DOI: 10.1007/s00216-016-9345-y  0.313
2016 Salem ME, Wang H, Fakih M, Mikhail S, Smaglo BG, Pishvaian MJ, He AR, Weiner LM, Bekaii-Saab TS, Marshall J. An open-label, multi-center, phase 2 study of switch maintenance with TAS-102 plus bevacizumab following oxaliplatin or irinotecan-based fluoropyrimidine-containing induction chemotherapy in patients with metastatic colorectal cancer: ALEXANDRIA study. Journal of Clinical Oncology. 34: TPS3624-TPS3624. DOI: 10.1200/Jco.2016.34.15_Suppl.Tps3624  0.314
2015 Gao Y, Sun Q, Liu D, Ma B, Zhao H, Fang Z, Wang H, Lou H. A sensitive LC-MS/MS method to quantify methylergonovine in human plasma and its application to a pharmacokinetic study. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences. 1011: 62-68. PMID 26760224 DOI: 10.1016/j.jchromb.2015.12.046  0.308
2015 Chai L, Dong S, Zhao H, Deng H, Wang H. Effects of fluoride on development and growth of Rana chensinensis embryos and larvae. Ecotoxicology and Environmental Safety. 126: 129-137. PMID 26745004 DOI: 10.1016/j.ecoenv.2015.12.015  0.3
2014 He AR, Tesfaye A, Smith D, Marshall J, Pishvaian MJ, Smaglo BG, Weiner LM, Dorsch-Vogel K, Wang H. Phase II trial of temozolomide and veliparib combination therapy for sorafenib-refractory advanced hepatocellular carcinoma (HCC). Journal of Clinical Oncology. 32: 240-240. DOI: 10.1200/Jco.2014.32.3_Suppl.240  0.304
2013 Pishvaian MJ, Wang H, Zhuang T, He AR, Hwang JJ, Hankin A, Ley L, White K, Littman SJ, Weiner LM, Marshall J, Brody JR. A phase I/II study of ABT-888 in combination with 5-fluorouracil (5-FU) and oxaliplatin (Ox) in patients with metastatic pancreatic cancer (MPC). Journal of Clinical Oncology. 31: 147-147. DOI: 10.1200/Jco.2013.31.4_Suppl.147  0.302
2013 Smaglo BG, Wang H, Steadman K, Murray J, Pishvaian M, He AR, Hwang JJ, Subramaniam DS, Deeken JF, Weiner LM. A phase I study of the BCR-ABL tyrosine kinase inhibitor nilotinib and cetuximab in patients with solid tumors that can be treated with cetuximab. Journal of Clinical Oncology. 31: TPS2624-TPS2624. DOI: 10.1200/Jco.2013.31.15_Suppl.Tps2624  0.321
2013 Deeken JF, Wang H, Marshall J, Subramaniam DS, Hwang JJ, He AR, Ramos C, Hardesty RA, Steadman K, Weiner LM, Pishvaian MJ. Final results of a phase I study of lapatinib (LAP) and cetuximab (CET) in patients with CET-sensitive solid tumors. Journal of Clinical Oncology. 31: 2616-2616. DOI: 10.1200/Jco.2013.31.15_Suppl.2616  0.306
2012 Deeken JF, Wang H, Hwang JJ, Marshall J, Subramaniam DS, He AR, Weiner LM, Hardesty RA, Steadman K, Pishvaian MJ. A phase I study of lapatinib (LPT) and cetuximab (CTX) in patients with CTX-sensitive solid tumors. Journal of Clinical Oncology. 30: 2590-2590. DOI: 10.1200/Jco.2012.30.15_Suppl.2590  0.308
2008 Wang H, Zhao H. A study on confidence intervals for incremental cost-effectiveness ratios. Biometrical Journal. Biometrische Zeitschrift. 50: 505-14. PMID 18663759 DOI: 10.1002/Bimj.200810439  0.41
2007 Noyes K, Corona E, Zwanziger J, Hall WJ, Zhao H, Wang H, Moss AJ, Dick AW. Health-related quality of life consequences of implantable cardioverter defibrillators: results from MADIT II. Medical Care. 45: 377-85. PMID 17446823 DOI: 10.1097/01.Mlr.0000257142.12600.C1  0.391
2007 Blumberg N, Zhao H, Wang H, Messing S, Heal JM, Lyman GH. The intention-to-treat principle in clinical trials and meta-analyses of leukoreduced blood transfusions in surgical patients. Transfusion. 47: 573-81. PMID 17381614 DOI: 10.1111/J.1537-2995.2007.01158.X  0.421
2007 Zhao H, Bang H, Wang H, Pfeifer PE. On the equivalence of some medical cost estimators with censored data. Statistics in Medicine. 26: 4520-30. PMID 17380543 DOI: 10.1002/Sim.2882  0.4
2007 Wang H, Zhao H. Regression analysis of mean quality-adjusted lifetime with censored data. Biostatistics (Oxford, England). 8: 368-82. PMID 16877496 DOI: 10.1093/Biostatistics/Kxl016  0.402
2006 Wang H, Zhao H. Estimating incremental cost-effectiveness ratios and their confidence intervals with differentially censored data. Biometrics. 62: 570-5. PMID 16918922 DOI: 10.1111/J.1541-0420.2005.00502.X  0.409
2006 Zwanziger J, Hall WJ, Dick AW, Zhao H, Mushlin AI, Hahn RM, Wang H, Andrews ML, Mooney C, Wang H, Moss AJ. The cost effectiveness of implantable cardioverter-defibrillators: results from the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II. Journal of the American College of Cardiology. 47: 2310-8. PMID 16750701 DOI: 10.1016/J.Jacc.2006.03.032  0.386
Show low-probability matches.